https://adisinsight.springer.com/trials/700392037?error=cookies_not_supported&code=268db864-4ef7-4339-aed4-6618bcacc39f
A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate ISH0688 Subcutaneous...
ISH0688 is a human IgG1 Fc-FGF21 fusion protein. The objectives of the planned clinical investigation will be to evaluate the safety, tolerability,